share_log

AstraZeneca | 6-K: FY and Q4 2023 Results

SEC announcement ·  Feb 8 06:45
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more